View in EDS

Dose-Expansion Study of OBI-999, a Globo H-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors.

Saved in:
Bibliographic Details
Title: Dose-Expansion Study of OBI-999, a Globo H-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors.
Authors: Tsimberidou AM; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX., Sigal D; Scripps Clinic and Scripps Cancer Center, La Jolla, CA., Varghese A; Memorial Sloan Kettering Cancer Center, New York, NY., Vaena D; West Cancer Center & Research Institute, Germantown, TN., Bai LY; China Medical University Hospital, Taichung, Taiwan., Chen MH; Taipei Veteran General Hospital, Taipei, Taiwan., Yeh CN; Chang Gung Memorial Hospital, Taipei City, Taiwan., Yen CJ; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Baysal MA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX., Chakraborty A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX., Lee I; OBI Pharma Inc, Taipei City, Taiwan., Shia CS; OBI Pharma Inc, Taipei City, Taiwan., Ristoski K; OBI Pharma USA, Inc, San Diego, CA., Xu D; OBI Pharma USA, Inc, San Diego, CA.
Source: The oncologist [Oncologist] 2026 Jun 29. Date of Electronic Publication: 2026 Jun 29.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42371780
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dose-Expansion Study of OBI-999, a Globo H-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tsimberidou+AM%22">Tsimberidou AM</searchLink>; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Sigal+D%22">Sigal D</searchLink>; Scripps Clinic and Scripps Cancer Center, La Jolla, CA.<br /><searchLink fieldCode="AU" term="%22Varghese+A%22">Varghese A</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Vaena+D%22">Vaena D</searchLink>; West Cancer Center & Research Institute, Germantown, TN.<br /><searchLink fieldCode="AU" term="%22Bai+LY%22">Bai LY</searchLink>; China Medical University Hospital, Taichung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+MH%22">Chen MH</searchLink>; Taipei Veteran General Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Yeh+CN%22">Yeh CN</searchLink>; Chang Gung Memorial Hospital, Taipei City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Yen+CJ%22">Yen CJ</searchLink>; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Baysal+MA%22">Baysal MA</searchLink>; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Chakraborty+A%22">Chakraborty A</searchLink>; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Lee+I%22">Lee I</searchLink>; OBI Pharma Inc, Taipei City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Shia+CS%22">Shia CS</searchLink>; OBI Pharma Inc, Taipei City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Ristoski+K%22">Ristoski K</searchLink>; OBI Pharma USA, Inc, San Diego, CA.<br /><searchLink fieldCode="AU" term="%22Xu+D%22">Xu D</searchLink>; OBI Pharma USA, Inc, San Diego, CA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229607837%22">The oncologist</searchLink> [Oncologist] 2026 Jun 29. <i>Date of Electronic Publication: </i>2026 Jun 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9607837 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1549-490X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210837159%22">10837159 </searchLink><i>NLM ISO Abbreviation: </i>Oncologist <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42371780
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/oncolo/oyag249
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Dose-Expansion Study of OBI-999, a Globo H-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tsimberidou AM
      – PersonEntity:
          Name:
            NameFull: Sigal D
      – PersonEntity:
          Name:
            NameFull: Varghese A
      – PersonEntity:
          Name:
            NameFull: Vaena D
      – PersonEntity:
          Name:
            NameFull: Bai LY
      – PersonEntity:
          Name:
            NameFull: Chen MH
      – PersonEntity:
          Name:
            NameFull: Yeh CN
      – PersonEntity:
          Name:
            NameFull: Yen CJ
      – PersonEntity:
          Name:
            NameFull: Baysal MA
      – PersonEntity:
          Name:
            NameFull: Chakraborty A
      – PersonEntity:
          Name:
            NameFull: Lee I
      – PersonEntity:
          Name:
            NameFull: Shia CS
      – PersonEntity:
          Name:
            NameFull: Ristoski K
      – PersonEntity:
          Name:
            NameFull: Xu D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 06
              Text: 2026 Jun 29
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1549-490X
          Titles:
            – TitleFull: The oncologist
              Type: main
ResultId 1